Active, Not Recruiting
Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer
NCT04238624
- Conditions
- Anaplastic Thyroid Cancer, BRAF Gene Mutation, BRAF Mutation-Related Tumors, +12 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Commack (Limited Protocol Activities) Commack, New York, United States